Paul V. O’Donnell
0000-0002-8521-6024
Publication & Citation Trends
Publications
0 total
Incidence of and Risk Factors for Delayed Engraftment after Post-Transplant Cyclophosphamide.
Cited by 0
Semantic Scholar
Reduced Dose Post-Transplant Cyclophosphamide in Allogeneic Hematopoietic Cell Transplant
Cited by 0
Semantic Scholar
Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT.
Cited by 14
Semantic Scholar
Safe and effective addition of ruxolitinib to graft-versus-host prophylaxis in older adults undergoing reduced-intensity allogeneic hematopoietic cell transplantation.
Cited by 1
Semantic Scholar
Suboptimal Engraftment and Toxicity after Post-Transplant Cyclophosphamide
Cited by 0
Semantic Scholar
Third-party fecal microbiota transplantation for high-risk treatment-naïve acute GVHD of the lower GI tract OA
Cited by 17
Semantic Scholar
Factors Associated with Increased Risk of Contamination in Bone Marrow Transplants.
Cited by 0
Semantic Scholar
Research Topics
Hematopoietic Stem Cell Transplantation
(109)
Acute Lymphoblastic Leukemia research
(31)
Acute Myeloid Leukemia Research
(26)
Immune Cell Function and Interaction
(25)
Renal Transplantation Outcomes and Treatments
(24)
Affiliations
Commonwealth Scientific and Industrial Research Organisation
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
Seattle Cancer Care Alliance
Memorial Sloan Kettering Cancer Center
The University of Texas MD Anderson Cancer Center